Trial Profile
A dose-finding phase I trial of GP 1681 in healthy adults.
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 14 May 2015
Price :
$35
*
At a glance
- Drugs GP 1681 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; First in man
- Sponsors Gemmus Pharma
- 14 May 2015 New trial record